The REthinking MeAsures of DivErsity (REMADE) Study: Developing New Diversity Measures to Ensure Fair Representation in Clinical Trials (P1-1.011)
Develop and test questions that more accurately capture patient diversity via socioeconomic, cultural, and ethnic parameters versus the standard set of demographic questions used in clinical trials.
Authors
- Eddilisa Martin
- Adrian Kielhorn
- Jeffrey Yu (ORCID: https://orcid.org/0000-0003-3067-6813)
- Nuwan Kurukulasuriya
- Marcus L. Martin
- Kelly McNeil-Posey
- Barbara Mungin
- Wendy Erler
- Yu Xia
- James Murdoch
Institutions
- AstraZeneca (Brazil) (BR)
- Alexion Pharma (Switzerland) (CH)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208391
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00